Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.1980
-0.0030 (-1.49%)
At close: Nov 16, 2026, 4:00 PM EST
0.1771
-0.0209 (-10.56%)
After-hours: Nov 16, 2026, 4:49 PM EST
Oragenics Market Cap
Oragenics has a market cap or net worth of $893.37 thousand as of November 16, 2026. It is the 49,568th most valuable company in the world and the 6,693rd biggest in the United States. Its market cap has decreased by 80.99% in one year.
Market Cap
893.37K
Enterprise Value
-937.43K
1-Year Change
-80.99%
Global Rank
Country Rank
#6,693 United States
Category
ChartMarket Cap Chart
Since February 27, 2004, Oragenics's market cap has decreased from $53.10M to $893.37K, a decrease of -98.32%. That is a compound annual growth rate of -16.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 893.37K | -72.93% |
| Dec 31, 2025 | 3.30M | -26.67% |
| Dec 31, 2024 | 4.50M | -68.97% |
| Dec 29, 2023 | 14.50M | 17.89% |
| Dec 30, 2022 | 12.30M | -76.30% |
| Dec 31, 2021 | 51.90M | 89.42% |
| Dec 31, 2020 | 27.40M | 13.69% |
| Dec 31, 2019 | 24.10M | -4.74% |
| Dec 31, 2018 | 25.30M | 118.10% |
| Dec 29, 2017 | 11.60M | -56.23% |
| Dec 30, 2016 | 26.50M | -51.55% |
| Dec 31, 2015 | 54.70M | 69.88% |
| Dec 31, 2014 | 32.20M | -62.43% |
| Dec 31, 2013 | 85.70M | 18.53% |
| Dec 31, 2012 | 72.30M | 1,125.42% |
| Dec 30, 2011 | 5.90M | -65.29% |
| Dec 31, 2010 | 17.00M | -37.50% |
| Dec 31, 2009 | 27.20M | 186.32% |
| Dec 31, 2008 | 9.50M | -17.39% |
| Dec 31, 2007 | 11.50M | -50.00% |
| Dec 29, 2006 | 23.00M | 253.85% |
| Dec 30, 2005 | 6.50M | -88.18% |
| Dec 31, 2004 | 55.00M | 3.58% |
| Feb 27, 2004 | 53.10M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 1.28M |
| Onconetix | 1.27M |
| Propanc Biopharma | 1.23M |
| Endovia Health Sciences | 1.17M |
| Artelo Biosciences | 1.13M |
| Bone Biologics | 1.10M |
| Matinas BioPharma Holdings | 881.57K |
| SciSparc | 869.84K |